Thursday, November 19, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· October 12, 2026

Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance

View original at finance.yahoo.com
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J…
Opening lines of the source · Yahoo Finance · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Board believes Appio's deep knowledge of the business, global leadership experience and longstanding connection to Bausch + Lomb position him well to build on the company's momentum and lead its next phase of growth.

    60% confidence
  • Saunders believes Bausch + Lomb is stronger, more focused and better positioned for the future, with a clearer strategy, a more robust pipeline and significant opportunities ahead.

    60% confidence
  • Bausch Health (excluding Bausch + Lomb) has delivered 13 consecutive quarters of year-over-year growth in revenue and adjusted EBITDA (non-GAAP) under Appio's leadership.

    60% confidence
  • Appio embraces the opportunity to lead Bausch + Lomb, which is built on its people, portfolio and commitment to customers and patients, and is well positioned to build on its momentum and deliver sustainable growth.

    60% confidence
  • Bausch + Lomb and Bausch Health currently expect to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D guidance, based on preliminary third-quarter results.

    60% confidence

Cited in these Via News reports